Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × lorlatinib × Thoracic × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

OTHER 22 INDUSTRY 15 OTHER_GOV 1 NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 38 Carboplatin 38 Paclitaxel 32 Radiotherapy 29 Docetaxel 17 Etoposide 16 Pemetrexed 15 Gemcitabine 15 Bevacizumab 10 Radiosurgery 9 Magnetic Resonance Spectroscopy 8 durvalumab 7 Taxes 7 Ramucirumab 6 Erlotinib Hydrochloride 6 Cetuximab 6 pembrolizumab 5 Specimen Handling 5 Irinotecan 5 Gene Expression Profiling 5 Filgrastim 5 cediranib 4 Vinorelbine 4 Polymerase Chain Reaction 4 Neoadjuvant Therapy 4 Chemotherapy, Adjuvant 4 Amplified Fragment Length Polymorphism Analysis 4 tremelimumab 3 osimertinib 3 Watchful Waiting 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04127110 2024-11-05

ALKALINE

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡